Kewaunee Scientific Corporation (NASDAQ:KEQU) CFO Donald T. Gardner III Sells 3,000 Shares

Key Points

• Donald T. Gardner III, CFO of Kewaunee Scientific Corporation, sold 3,000 shares for approximately $175,770, reducing his ownership by 17.08% to 14,564 shares valued at around $853,304.76.
• As of the latest trading report, Kewaunee Scientific's stock is currently trading at $57.35, with a 1-year range between $30.33 and $71.33.
• Recent analysts upgrades raised the stock's rating from "hold" to "buy", indicating positive market sentiment.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CFO Donald T. Gardner III sold 3,000 shares of the business's stock in a transaction that occurred on Thursday, July 24th. The stock was sold at an average price of $58.59, for a total transaction of $175,770.00. Following the completion of the transaction, the chief financial officer owned 14,564 shares in the company, valued at $853,304.76. This trade represents a 17.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Kewaunee Scientific Trading Up 1.3%

Shares of Kewaunee Scientific stock traded up $0.69 on Friday, reaching $56.03. 6,656 shares of the company's stock were exchanged, compared to its average volume of 19,106. The company has a market capitalization of $165.30 million, a P/E ratio of 14.68 and a beta of 0.70. Kewaunee Scientific Corporation has a 52 week low of $30.33 and a 52 week high of $71.33. The firm's 50-day moving average is $48.44 and its two-hundred day moving average is $47.43. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.59 and a current ratio of 2.20.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its quarterly earnings results on Wednesday, June 25th. The technology company reported $1.95 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 26.02% and a net margin of 4.74%. The firm had revenue of $77.15 million for the quarter.

Institutional Investors Weigh In On Kewaunee Scientific

Several large investors have recently added to or reduced their stakes in KEQU. Bank of America Corp DE grew its holdings in Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after buying an additional 443 shares in the last quarter. IFP Advisors Inc grew its holdings in shares of Kewaunee Scientific by 61.5% during the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock worth $37,000 after purchasing an additional 360 shares in the last quarter. Morgan Dempsey Capital Management LLC grew its holdings in shares of Kewaunee Scientific by 41.8% during the second quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company's stock worth $247,000 after purchasing an additional 1,247 shares in the last quarter. Wedbush Securities Inc. purchased a new stake in Kewaunee Scientific in the fourth quarter worth approximately $262,000. Finally, OMERS ADMINISTRATION Corp purchased a new stake in Kewaunee Scientific in the first quarter worth approximately $284,000. Hedge funds and other institutional investors own 32.69% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a report on Saturday, July 5th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.